Cargando…
Impact of echinocandins as first-choice therapy in cardiothoracic high-risk patients with candidemia
Autores principales: | Langebartels, G, Choi, Y, Catteleans, J, Wahlers, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642960/ http://dx.doi.org/10.1186/cc12023 |
Ejemplares similares
-
146 Review of Empiric Echinocandin Therapy for Candidemia
por: Amado, Cristina, et al.
Publicado: (2014) -
372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018) -
Impact of patient frailty on outcome in cardiothoracic surgery
por: Brohan, J, et al.
Publicado: (2015) -
Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia
por: Sakai, Daiki, et al.
Publicado: (2021) -
Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
por: Ning, Yating, et al.
Publicado: (2022)